Thoracic Drainage Devices Market (Product: Thoracic Drainage Systems, Trocar Drains, Unsecured Needles, Secured Needles, Pleural Drainage Catheters, and Thoracic Drainage Kits) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-20

Thoracic Drainage Devices Market (Product: Thoracic Drainage Systems, Trocar Drains, Unsecured Needles, Secured Needles, Pleural Drainage Catheters, and Thoracic Drainage Kits) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Thoracic Drainage Devices Market – Scope of Report
TMR’s report on the global thoracic drainage devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global thoracic drainage devices market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global thoracic drainage devices market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the thoracic drainage devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global thoracic drainage devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global thoracic drainage devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global thoracic drainage devices market.

The report delves into the competitive landscape of the global thoracic drainage devices market. Key players operating in the global thoracic drainage devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global thoracic drainage devices market profiled in this report.

RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market thoracic drainage devices.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Thoracic Drainage Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Thoracic Drainage Devices Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Key Mergers & Acquisitions
5.3. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)
6. Global Thoracic Drainage Devices Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Thoracic Drainage System
6.3.2. Pleural Drainage Catheter
6.3.3. Secured Needle
6.3.4. Thoracic Drainage Kit
6.3.5. Thoracic Drainage System
6.3.6. Trocar Drain
6.3.7. Unsecured Needle
6.4. Market Attractiveness Analysis, by Product Type
7. Global Thoracic Drainage Devices Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Cardiac Surgery
7.3.2. General Intensive Care & Emergency Medicine
7.3.3. Infectious Disease
7.3.4. Military/Damage Control/Disaster Medicine
7.3.5. Oncology & Pain Management
7.3.6. Thoracic Surgery & Pulmonology
7.3.7. Other
7.4. Market Attractiveness Analysis, by Application
8. Global Thoracic Drainage Devices Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Ambulance Services
8.3.2. Ambulatory Surgery Centers
8.3.3. Hospitals & Specialty Clinics
8.3.4. Military Surgeons
8.3.5. Urgent Care or Outpatient Care
8.4. Market Attractiveness Analysis, by End-user
9. Global Thoracic Drainage Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Thoracic Drainage Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Thoracic Drainage System
10.2.2. Pleural Drainage Catheter
10.2.3. Secured Needle
10.2.4. Thoracic Drainage Kit
10.2.5. Thoracic Drainage System
10.2.6. Trocar Drain
10.2.7. Unsecured Needle
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Cardiac Surgery
10.3.2. General Intensive Care & Emergency Medicine
10.3.3. Infectious Disease
10.3.4. Military/Damage Control/Disaster Medicine
10.3.5. Oncology & Pain Management
10.3.6. Thoracic Surgery & Pulmonology
11. Europe Thoracic Drainage Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Thoracic Drainage System
11.2.2. Pleural Drainage Catheter
11.2.3. Secured Needle
11.2.4. Thoracic Drainage Kit
11.2.5. Thoracic Drainage System
11.2.6. Trocar Drain
11.2.7. Unsecured Needle
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Cardiac Surgery
11.3.2. General Intensive Care & Emergency Medicine
11.3.3. Infectious Disease
11.3.4. Military/Damage Control/Disaster Medicine
11.3.5. Oncology & Pain Management
11.3.6. Thoracic Surgery & Pulmonology
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Ambulance Services
11.4.2. Ambulatory Surgery Centers
11.4.3. Hospitals & Specialty Clinics
11.4.4. Military Surgeons
11.4.5. Urgent Care or Outpatient Care
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Thoracic Drainage Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Thoracic Drainage System
12.2.2. Pleural Drainage Catheter
12.2.3. Secured Needle
12.2.4. Thoracic Drainage Kit
12.2.5. Thoracic Drainage System
12.2.6. Trocar Drain
12.2.7. Unsecured Needle
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Cardiac Surgery
12.3.2. General Intensive Care & Emergency Medicine
12.3.3. Infectious Disease
12.3.4. Military/Damage Control/Disaster Medicine
12.3.5. Oncology & Pain Management
12.3.6. Thoracic Surgery & Pulmonology
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Ambulance Services
12.4.2. Ambulatory Surgery Centers
12.4.3. Hospitals & Specialty Clinics
12.4.4. Military Surgeons
12.4.5. Urgent Care or Outpatient Care
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Thoracic Drainage Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Thoracic Drainage System
13.2.2. Pleural Drainage Catheter
13.2.3. Secured Needle
13.2.4. Thoracic Drainage Kit
13.2.5. Thoracic Drainage System
13.2.6. Trocar Drain
13.2.7. Unsecured Needle
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Cardiac Surgery
13.3.2. General Intensive Care & Emergency Medicine
13.3.3. Infectious Disease
13.3.4. Military/Damage Control/Disaster Medicine
13.3.5. Oncology & Pain Management
13.3.6. Thoracic Surgery & Pulmonology
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Ambulance Services
13.4.2. Ambulatory Surgery Centers
13.4.3. Hospitals & Specialty Clinics
13.4.4. Military Surgeons
13.4.5. Urgent Care or Outpatient Care
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Thoracic Drainage Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Thoracic Drainage System
14.2.2. Pleural Drainage Catheter
14.2.3. Secured Needle
14.2.4. Thoracic Drainage Kit
14.2.5. Thoracic Drainage System
14.2.6. Trocar Drain
14.2.7. Unsecured Needle
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Cardiac Surgery
14.3.2. General Intensive Care & Emergency Medicine
14.3.3. Infectious Disease
14.3.4. Military/Damage Control/Disaster Medicine
14.3.5. Oncology & Pain Management
14.3.6. Thoracic Surgery & Pulmonology
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Ambulance Services
14.4.2. Ambulatory Surgery Centers
14.4.3. Hospitals & Specialty Clinics
14.4.4. Military Surgeons
14.4.5. Urgent Care or Outpatient Care
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.3. Company Profiles
15.3.1. Teleflex Incorporated
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. Vygon S.A.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Medtronic plc
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Strategic Overview
15.3.4. Cook Medical
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. C. R. Bard, Inc. (Becton, Dickinson and Company)
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. MAQUET Holding B.V. & Co. KG (Getinge Group)
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Strategic Overview
15.3.7. Utah Medical Products, Inc.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Smiths Medical
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. ATMOS MedizinTechnik GmbH & Co. KG
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview
15.3.10. Medela
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Strategic Overview
15.3.11. Rocket Medical plc
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Strategic Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings